Literature DB >> 21763757

Central sensitization of nociceptive neurons in rat medullary dorsal horn involves purinergic P2X7 receptors.

K Itoh1, C-Y Chiang, Z Li, J-C Lee, J O Dostrovsky, B J Sessle.   

Abstract

Central sensitization is a crucial process underlying the increased neuronal excitability of nociceptive pathways following peripheral tissue injury and inflammation. Our previous findings have suggested that extracellular adenosine 5'-triphosphate (ATP) molecules acting at purinergic receptors located on presynaptic terminals (e.g., P2X2/3, P2X3 subunits) and glial cells are involved in the glutamatergic-dependent central sensitization induced in medullary dorsal horn (MDH) nociceptive neurons by application to the tooth pulp of the inflammatory irritant mustard oil (MO). Since growing evidence indicates that activation of P2X7 receptors located on glia is involved in chronic inflammatory and neuropathic pain, the aim of the present study was to test in vivo for P2X7 receptor involvement in this acute inflammatory pain model. Experiments were carried out in anesthetized Sprague-Dawley male rats. Single unit recordings were made in MDH functionally identified nociceptive neurons for which mechanoreceptive field, mechanical activation threshold and responses to noxious stimuli were tested. We found that continuous intrathecal (i.t.) superfusion over MDH of the potent P2X7 receptor antagonists brilliant blue G and periodated oxidized ATP could each significantly attenuate the MO-induced MDH central sensitization. MDH central sensitization could also be produced by i.t. superfusion of ATP and even more effectively by the P2X7 receptor agonist benzoylbenzoyl ATP. Superfusion of the microglial blocker minocycline abolished the MO-induced MDH central sensitization, consistent with reports that dorsal horn P2X7 receptors are mostly expressed on microglia. In control experiments, superfusion over MDH of vehicle did not produce any significant changes. These novel findings suggest that activation of P2X7 receptors in vivo may be involved in the development of central sensitization in an acute inflammatory pain model.
Copyright © 2011 IBRO. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763757      PMCID: PMC3172718          DOI: 10.1016/j.neuroscience.2011.06.083

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  62 in total

1.  P2X7 receptor inhibition improves recovery after spinal cord injury.

Authors:  Xiaohai Wang; Gregory Arcuino; Takahiro Takano; Jane Lin; Wei Guo Peng; Pinglan Wan; Pingjia Li; Qiwu Xu; Qing Song Liu; Steven A Goldman; Maiken Nedergaard
Journal:  Nat Med       Date:  2004-07-18       Impact factor: 53.440

2.  The lumbar spinal cord glial cells actively modulate subcutaneous formalin induced hyperalgesia in the rat.

Authors:  Ming Qin; Jing-Jie Wang; Rong Cao; Hui Zhang; Li Duan; Bei Gao; Ying-Fei Xiong; Liang-Wei Chen; Zhi-Ren Rao
Journal:  Neurosci Res       Date:  2006-06-08       Impact factor: 3.304

3.  2',3'-O-(2,4,6- trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP)--a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels.

Authors:  C J Lewis; A Surprenant; R J Evans
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

4.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation.

Authors:  Annemarie Ledeboer; Evan M Sloane; Erin D Milligan; Matthew G Frank; John H Mahony; Steven F Maier; Linda R Watkins
Journal:  Pain       Date:  2005-05       Impact factor: 6.961

5.  A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.

Authors:  Prisca Honore; Diana Donnelly-Roberts; Marian T Namovic; Gin Hsieh; Chang Z Zhu; Joe P Mikusa; Gricelda Hernandez; Chengmin Zhong; Donna M Gauvin; Prasant Chandran; Richard Harris; Arturo Perez Medrano; William Carroll; Kennan Marsh; James P Sullivan; Connie R Faltynek; Michael F Jarvis
Journal:  J Pharmacol Exp Ther       Date:  2006-09-18       Impact factor: 4.030

Review 6.  Pathological and protective roles of glia in chronic pain.

Authors:  Erin D Milligan; Linda R Watkins
Journal:  Nat Rev Neurosci       Date:  2009-01       Impact factor: 34.870

7.  Influence of the vanilloid receptor TRPV1 on the activation of spinal cord glia in mouse models of pain.

Authors:  Yong Chen; Helen H Willcockson; Juli G Valtschanoff
Journal:  Exp Neurol       Date:  2009-10-06       Impact factor: 5.330

8.  Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors.

Authors:  Diana L Donnelly-Roberts; Marian T Namovic; Ping Han; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2009-06-22       Impact factor: 8.739

9.  Inhibition of chemokine expression in rat inflamed paws by systemic use of the antihyperalgesic oxidized ATP.

Authors:  Alessandro Fulgenzi; Giacomo Dell'Antonio; Chiara Foglieni; Elena Dal Cin; Paolo Ticozzi; Josè S Franzone; Maria Elena Ferrero
Journal:  BMC Immunol       Date:  2005-07-22       Impact factor: 3.615

10.  Purinergic modulation of microglial cell activation.

Authors:  Beáta Sperlágh; Peter Illes
Journal:  Purinergic Signal       Date:  2006-12-19       Impact factor: 3.765

View more
  17 in total

1.  Functional properties of tooth pulp neurons responding to thermal stimulation.

Authors:  D K Ahn; E A Doutova; K McNaughton; A R Light; M Närhi; W Maixner
Journal:  J Dent Res       Date:  2012-01-17       Impact factor: 6.116

Review 2.  Role of astrocytes in pain.

Authors:  C-Y Chiang; B J Sessle; J O Dostrovsky
Journal:  Neurochem Res       Date:  2012-05-26       Impact factor: 3.996

Review 3.  P2X ion channel receptors and inflammation.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2016-01-06       Impact factor: 3.765

4.  Trigeminal nerve injury-induced thrombospondin-4 up-regulation contributes to orofacial neuropathic pain states in a rat model.

Authors:  K-W Li; D-S Kim; F Zaucke; Z D Luo
Journal:  Eur J Pain       Date:  2013-09-09       Impact factor: 3.931

5.  Decreased face primary motor cortex (face-M1) excitability induced by noxious stimulation of the rat molar tooth pulp is dependent on the functional integrity of medullary astrocytes.

Authors:  H Pun; L Awamleh; J-C Lee; L Avivi-Arber
Journal:  Exp Brain Res       Date:  2015-10-20       Impact factor: 1.972

6.  Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat.

Authors:  Zsuzsanna Bohár; Gábor Nagy-Grócz; Annamária Fejes-Szabó; Lilla Tar; Anna M László; Alexandra Büki; Nikolett Szabadi; Veronika Vraukó; László Vécsei; Árpád Párdutz
Journal:  J Neural Transm (Vienna)       Date:  2015-08-23       Impact factor: 3.575

Review 7.  P2X4 purinoceptor signaling in chronic pain.

Authors:  Tuan Trang; Michael W Salter
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

8.  Central α-adrenoceptors contribute to mustard oil-induced central sensitization in the rat medullary dorsal horn.

Authors:  H Wang; Y F Xie; C Y Chiang; J O Dostrovsky; B J Sessle
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

9.  Central sensitization and MAPKs are involved in occlusal interference-induced facial pain in rats.

Authors:  Ye Cao; Kai Li; Kai-Yuan Fu; Qiu-Fei Xie; Chen-Yu Chiang; Barry J Sessle
Journal:  J Pain       Date:  2013-05-01       Impact factor: 5.820

10.  P2X7R in Mast Cells is a Potential Target for Salicylic Acid and Aspirin in Treatment of Inflammatory Pain.

Authors:  Yucui Jiang; Fan Ye; Ying Du; Yingxin Zong; Zongxiang Tang
Journal:  J Inflamm Res       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.